BIOFLOW-III Belgium Satellite Registry

NCT01831336 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 332

Last updated 2017-09-28

No results posted yet for this study

Summary

This registry is a clinical post-market evaluation of the Orsiro LESS in subjects requiring coronary revascularization with Drug Eluting Stents (DES).

Conditions

Sponsors & Collaborators

  • Biotronik Belgium NV

    lead INDUSTRY

Principal Investigators

  • Victor Legrand, Prof. Dr. · CHU Liege (Hospitalo-Facultaire Universitaire de Liège)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01831336 on ClinicalTrials.gov